$GMAB / $ABBV Iโve spent some time reviewing the recent federal court filings and the ITC docket ๐ค. Here are my thoughts on the Rina-S trade-secret litigation. ๐งต
@bradloncar@BiotechTV $ROIV With IMVT-1402 advancing toward commercialization and Covant developing both oral and longer-acting FcRn inhibitors, how are you thinking about the potential overlap between those franchises?